What You Should Know: - Wavemaker Three-Sixty Health (Wavemaker 360), the nation’s leading venture fund focused on early-stage (primarily seed) healthcare disruptors and innovators, recently announced its Fund II news, closing at $64M, surpassing its first fund nearly four times over. - The goal for Fund II is to invest into 40-50 early-stage companies, with several investments already made into some of the most compelling healthcare start-ups in the areas of health-tech, digital health,
Read More
Artificial Intelligence in Healthcare | News, Analysis, Insights - HIT Consultant
Sanofi Launches Its First Digital Health Accelerator to Address Unmet Patient Needs
What You Should Know: - Sanofi launched its first Digital Accelerator to better leverage data and artificial intelligence to develop solutions that address unmet patient needs. - The Digital Accelerator team is developing an integrated platform and data solution to enhance awareness of atopic dermatitis and available treatment options amongst patients and HCPs. Digital Accelerator Focus The Digital Accelerator is the next step in Sanofi’s
Read More
AI for Behavioral Health Gets Boost With Ontrak-Eleos Partnership
What You Should Know: - Eleos Health, a behavioral health tech company and Ontrak Health (NASDAQ: OTRK), a healthcare company are teaming up to integrate their respective AI platforms to support behavioral health care for Ontrak’s members.- Ontrak specializes in serving the most vulnerable members of the behavioral health population who would otherwise fall through the cracks of the healthcare system. Eleos integration equips Ontrak’s behavioral health providers with greater insights into
Read More
Why Health Plans Must Have Next-Gen CAPS Technology for Digital Transformation
Core Administrative Processing Systems (CAPS) operate as the brains behind a health plan’s business. These systems are critical to the smooth functioning of a health plan. Today, many payers run on decades-old CAPS systems built on legacy technologies. This can be a serious drawback. Legacy systems may have been efficient based on the technology and best practices of decades past, but have aged beyond their time. They often require an increasing number of workarounds and fixes to try to
Read More
Insilico Medicine Raises $60M, Launches AI-powered Drug Discovery Robotics Laboratory
What You Should Know: - Insilico Medicine, an NYC-based clinical-stage end-to-end artificial intelligence (AI)-driven drug discovery company raises $60 million in Series D financing from a syndicate of global investors with expertise in investing in the biopharmaceutical and life sciences sectors. - Insilico is also launching a new state-of-the-art robotics lab and fully robotic biological data factory. They have seen a string of successes thus far in 2022, including the
Read More
4 Patient Flow Challenges Contributing to Provider Burnout
There has been frequent reporting about the problem of provider workforce shortages within hospitals and health systems and the related burnout experienced when working in high-stress situations during the COVID-19 pandemic. There are pre-existing and contributing patient flow challenges that have been exacerbated by the pandemic, which can lead to burnout, and therefore are worth discussing. Exposing the Problem The extent of provider burnout over the course of the pandemic is well
Read More
Lightbeam Health Acquires Jvion AI and SDOH Solutions – M&A
What You Should Know: – Lightbeam Health Solutions, Inc., a provider of population health management solutions and services has entered into an asset purchase agreement to acquire the operating assets related to Jvion, Inc., including Jvion’s market-leading AI-enabled prescriptive analytics and social determinants of health (SDoH) solutions. -The strategic partnership combines Lightbeam’s health analytics and outcomes for payers and providers with the Jvion’s predictive technology.
Read More
Survey: Patient Trust Not a Barrier to AI Medical Imaging Adoption
What You Should Know: According to data from Intelerad, patient trust is not a barrier to AI adoption by medical imaging professionals in the U.S. 64% of respondents either trust or are neutral about a diagnosis solely from AI. The Intelerad study of over 1,000 healthcare consumers across the U.S. uncovers the impact of healthcare’s digital transformation on the healthcare consumer in a post-pandemic world. The results unveil new insights into patient attitudes toward AI. Patient
Read More
Geisinger & Tempus Create AI Model to Identify Structural Heart Disease
What You Should Know: - Tempus, an $8B precision medicine company, announced a collaborative study with Geisinger focusing on artificial intelligence (AI) model that can accurately identify patients at increased risk of undiagnosed structural heart disease (SHD). The study addresses a critical diagnostic gap – SHD is a progressive disease that affects the valves, walls, chambers, and muscles of the heart, and causes debilitating symptoms or death, yet many patients with the disease go
Read More
RapidAI Receives FDA 510(k) Clearance for Pulmonary Embolism Triage & Notification
What You Should Know: - RapidAI, a neurovascular and vascular AI-enhanced clinical decision support and patient workflow receives FDA 510(k) clearance for its Rapid PE Triage & Notification product for fast identification and communication of suspected central pulmonary embolism — further strengthening RapidAI’s industry-leading clinical AI platform. - Rapid PE Triage & Notification, in conjunction with Rapid Workflow for PE, will enable care teams to more
Read More
